Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.

Sharma A, Tan JK, Sisodia R, Kumar H, Bharadwaj HR, Sonaiya S, Shah Y, Ali H, Dhali A, Abdul RHM, Khan SA, Alsakarneh S, Dahiya DS, Mandal S

Open source

DOI: 10.3389/fonc.2026.1894185
Published: 2026
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1894185,
  title = {Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.},
  author = {Sharma A and Tan JK and Sisodia R and Kumar H and Bharadwaj HR and Sonaiya S and Shah Y and Ali H and Dhali A and Abdul RHM and Khan SA and Alsakarneh S and Dahiya DS and Mandal S},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1894185},
  url = {https://doi.org/10.3389/fonc.2026.1894185}
}

RIS

TY  - JOUR
TI  - Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.
AU  - Sharma A
AU  - Tan JK
AU  - Sisodia R
AU  - Kumar H
AU  - Bharadwaj HR
AU  - Sonaiya S
AU  - Shah Y
AU  - Ali H
AU  - Dhali A
AU  - Abdul RHM
AU  - Khan SA
AU  - Alsakarneh S
AU  - Dahiya DS
AU  - Mandal S
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1894185
UR  - https://doi.org/10.3389/fonc.2026.1894185
ER  -

APA

A, S., JK, T., R, S., H, K., HR, B., S, S., Y, S., H, A., A, D., RHM, A., SA, K., S, A., DS, D., & S, M. (2026). Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1894185

Source records

pubmed · retrieved 2026-09-25T12:24:03.609Z